Active Ingredient History

  • Now
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Achillion Pharmaceuticals, Inc. for the treatment of HIV infection.   Wikipedia

  • SMILES: NC1=NC(=O)N(C=C1F)[C@H]2O[C@@H](CO)C=C2
  • Mol. Mass: 227.19
  • ALogP: -0.59
  • ChEMBL Molecule:
More Chemistry
ach-126443 | ach-126-443 | ach126-443 | beta-l-fd4c | elvucitabine


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue